Search Results - rene+renteria

1 Results Sort By:
Dopamine 2 Receptor agonists as new therapeutics for Age Related Macular Degeneration and Diabetic Retinopathy
By understanding and controlling activation of specific dopamine receptors, we showed that the current dopamine pathway drugs can be used in new ways as new therapeutics to treat wet age-related macular degeneration (ARMD) and diabetic retinopathy (DR). It will reduce the chance of a side effect of conventional ARMD or DR therapy, leading to vision...
Published: 6/4/2021   |   Inventor(s): Jeong-Hyeon Sohn, Rene Renteria, Nikolay Akimov
Keywords(s):  
Category(s): Clinical Specialty > Opthamology, Therapeutics > Small Molecule